Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? (2023)

First Author: Owens L

Attributed to: Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1055-9965.epi-22-1307

PubMed Identifier: 37259797

Publication URI: http://europepmc.org/abstract/MED/37259797

Type: Journal Article/Review

Volume: 32

Parent Publication: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Issue: 6

ISSN: 1055-9965